FLOREANI, ANNAROSA
 Distribuzione geografica
Continente #
NA - Nord America 25.071
AS - Asia 9.666
EU - Europa 5.684
AF - Africa 2.538
SA - Sud America 2.125
OC - Oceania 251
Continente sconosciuto - Info sul continente non disponibili 115
Totale 45.450
Nazione #
US - Stati Uniti d'America 23.733
SG - Singapore 3.695
CN - Cina 1.638
HK - Hong Kong 1.223
BR - Brasile 1.205
VN - Vietnam 678
IT - Italia 669
DE - Germania 536
FI - Finlandia 533
SE - Svezia 365
PL - Polonia 363
UA - Ucraina 298
FR - Francia 268
RU - Federazione Russa 251
GB - Regno Unito 250
NL - Olanda 216
AR - Argentina 196
IN - India 135
MX - Messico 127
TR - Turchia 124
AT - Austria 123
IE - Irlanda 115
IQ - Iraq 114
CI - Costa d'Avorio 112
CO - Colombia 97
ES - Italia 97
CR - Costa Rica 95
JP - Giappone 93
AO - Angola 91
AE - Emirati Arabi Uniti 90
MA - Marocco 89
EC - Ecuador 87
PE - Perù 86
ZA - Sudafrica 86
UY - Uruguay 85
PH - Filippine 84
PY - Paraguay 84
VE - Venezuela 84
BJ - Benin 83
ID - Indonesia 83
CG - Congo 82
DK - Danimarca 81
HU - Ungheria 77
PR - Porto Rico 76
SI - Slovenia 74
CA - Canada 72
DO - Repubblica Dominicana 72
KZ - Kazakistan 72
DZ - Algeria 71
LB - Libano 71
SN - Senegal 71
YT - Mayotte 71
BB - Barbados 70
BE - Belgio 70
BF - Burkina Faso 70
JO - Giordania 70
TN - Tunisia 70
AZ - Azerbaigian 69
PA - Panama 69
TT - Trinidad e Tobago 69
BD - Bangladesh 68
BO - Bolivia 68
EE - Estonia 68
GT - Guatemala 68
KR - Corea 68
PK - Pakistan 68
TJ - Tagikistan 68
UZ - Uzbekistan 68
BA - Bosnia-Erzegovina 67
CL - Cile 67
HN - Honduras 67
MG - Madagascar 67
PT - Portogallo 67
RS - Serbia 67
IR - Iran 66
MK - Macedonia 66
SA - Arabia Saudita 66
AL - Albania 65
EG - Egitto 65
GF - Guiana Francese 65
IL - Israele 65
LA - Repubblica Popolare Democratica del Laos 65
NO - Norvegia 65
HR - Croazia 64
AM - Armenia 63
CV - Capo Verde 63
DJ - Gibuti 63
GA - Gabon 63
ML - Mali 63
PS - Palestinian Territory 63
TH - Thailandia 63
BZ - Belize 62
CY - Cipro 62
CZ - Repubblica Ceca 62
GN - Guinea 62
MZ - Mozambico 62
NZ - Nuova Zelanda 62
RE - Reunion 62
BG - Bulgaria 61
KG - Kirghizistan 61
Totale 42.423
Città #
Fairfield 3.474
Ashburn 2.391
Woodbridge 2.251
Singapore 1.954
Houston 1.811
Ann Arbor 1.590
Chandler 1.398
Wilmington 1.296
Seattle 1.270
Cambridge 1.204
Hong Kong 1.167
Jacksonville 1.108
Beijing 509
Boardman 500
Princeton 500
Santa Clara 386
San Diego 360
Bytom 266
Medford 241
Nanjing 204
Helsinki 190
Ho Chi Minh City 188
Des Moines 184
Padova 178
Roxbury 177
Los Angeles 168
Dong Ket 160
New York 129
Abidjan 109
Chicago 104
Hanoi 104
São Paulo 89
Dublin 87
Munich 83
Vienna 82
Cotonou 78
San José 73
Luanda 72
Dakar 69
Montevideo 67
Panama City 66
Amman 65
Bridgetown 65
Guangzhou 64
London 63
Dushanbe 62
Tashkent 62
Baku 61
Bamako 60
Buffalo 60
Conakry 59
Libreville 59
Antananarivo 58
Bishkek 57
Vientiane 57
Hebei 54
Nouakchott 54
Praia 54
Yerevan 54
Shenyang 53
Andorra la Vella 52
Phnom Penh 52
Podgorica 52
Dallas 51
Djibouti 51
Havana 51
Managua 51
Norwalk 51
Ulan Bator 51
Willemstad 51
Brooklyn 50
Castries 50
Kampala 50
Nairobi 50
Nanchang 50
Lima 49
Niamey 49
Brazzaville 48
Mamoudzou 48
Ouagadougou 48
Tallinn 48
Auckland 47
Noumea 47
Accra 46
Kigali 46
Lusaka 46
Amsterdam 45
Cayenne 45
Jiaxing 45
Reykjavik 45
Maputo 44
Nassau 44
Tokyo 44
Nuremberg 43
Boston 42
Belgrade 41
Dili 41
Warsaw 41
Baghdad 40
Dar es Salaam 40
Totale 29.343
Nome #
Primary biliary cirrhosis: overlaps with other autoimmune disorders 249
Coronary flow reserve in patients with primary biliary cholangitis 215
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 214
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 211
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 210
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 202
Heparanase and macrophage interplay in the onset of liver fibrosis 202
Extrahepatic autoimmunity in autoimmune liver disease 202
Functional differentiation of human pluripotent stem cells on a chip 200
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 199
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 198
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 197
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis 195
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 194
Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis 193
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 192
In vitro metabolic zonation through oxygen gradient on a chip 192
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload 190
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation 189
Hepatitis C virus infection in pregnancy. 187
Colchicine in chronic hepatitis B: a pilot study 186
Is osteopenia a peculiar association with primary biliary cirrhosis (PBC)? 186
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy. 185
Functional differentiation of human pluripotent stem cells on a chip. 185
The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report 184
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 184
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 182
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)? 181
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 181
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 181
AISF position paper on liver disease and pregnancy 180
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 180
Acute hepatitis in elderly patients. 179
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 179
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 179
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 178
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 177
Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus 177
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications 176
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis 176
THE EARLY DIAGNOSIS IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS: A 35-YEAR FOLLOW-UP IN A SINGLE CENTRE 175
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 175
Bone metabolism in orthotopic liver transplantation: a prospective study. 174
HEPATOCELLULAR PROLIFERATION, TNF-ALPHA AND INFLAMMATION IN PRIMARY BILIARY-CIRRHOSIS (PBC) 173
Y chromosome loss in male patients with primary biliary cirrhosis 172
Are homes for the elderly still a risk area for HBV infection? 172
AISF position paper on liver transplantation and pregnancy. Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 172
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 171
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 171
Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. 170
Ursodeoxycholic Acid Therapy and Liver Transplant-free Survival in Patients with Primary Biliary Cholangitis 170
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a Southern European population 169
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 168
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 168
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 167
Viral load in HCV RNA-positive pregnant women. 167
Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome 167
Type 1 autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study 166
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 166
A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. 164
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 164
BRIC AUTOSOMAL DOMINANT BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC) UNLINKED TO 18Q 21 LOCUS: IS IT A NEW ENTITY? 163
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 163
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. 163
Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis. 163
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 162
Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. 162
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations 159
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 159
Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis 159
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis 158
New therapies for primary biliary cirrhosis 158
The early diagnosis improves survival in primary biliary cirrhosis: A 35-year follow-up in a single centre 158
Prevalence of familial disease in primary biliary cirrhosis in Italy 157
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 156
A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. 156
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 156
Preventative therapy in primary biliary cirrhosis 155
An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy 155
Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C 155
Primary biliary cirrhosis and hepatitis C virus infection 155
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. 155
Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis 155
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. 154
Primary biliary cholangitis: Old and novel therapy 154
Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. 154
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 153
Primary biliary cirrhosis: report of a focus study group. 152
Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program. 152
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 152
Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in a open population 152
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. 152
Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy 152
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 152
The natural history of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome 151
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. 151
Response to influenza vaccine in people with non-protective HI antibody titers. 151
Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C 151
Gender medicine: a task for the third millennium. 151
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE 151
Totale 17.275
Categoria #
all - tutte 143.680
article - articoli 130.539
book - libri 466
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.597
Totale 279.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.319 0 0 0 0 0 220 85 361 501 368 478 306
2021/20224.500 129 525 668 280 225 264 250 481 187 90 476 925
2022/20233.083 681 273 53 328 504 437 47 228 327 16 154 35
2023/20241.393 66 188 158 116 72 127 81 104 53 37 170 221
2024/20256.868 12 564 322 249 843 185 290 492 705 304 1.100 1.802
2025/202614.835 1.059 2.332 3.979 4.600 2.690 175 0 0 0 0 0 0
Totale 45.706